Axonics Modulation Technologies is a medical device company developing a neuromodulation platform based on miniaturized rechargeable technology directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder. The Axonics Sacral Neuromodulation System is a CE-marked rechargeable SNM system designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
|HQ||Irvine, CA, US||Map|
Gross profit (Q1, 2021)
Gross profit margin (Q1, 2021), %
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (31-Dec-2021)
Closing stock price (31-Dec-2021)
|USD||Q2, 2017||Q3, 2017||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020||Q1, 2021|
Depreciation and Amortization
When was Axonics founded?
Axonics was founded in 2013.
Who are Axonics key executives?
Axonics's key executives are Erik Amble, Guangqiang Jiang and Juliet Tammenoms Bakker.
How many employees does Axonics have?
Axonics has 302 employees.
What is Axonics revenue?
Latest Axonics annual revenue is $111.5 m.
What is Axonics revenue per employee?
Latest Axonics revenue per employee is $369.3 k.
Who are Axonics competitors?
Competitors of Axonics include TEMA SINERGIE, BSN Medical and Acelity.
Where is Axonics headquarters?
Axonics headquarters is located at 26 Technology Dr, Irvine.
Where are Axonics offices?
Axonics has an office in Irvine.
How many offices does Axonics have?
Axonics has 1 office.
Receive alerts for 300+ data fields across thousands of companies